BOSTON, June 13, 2019 /PRNewswire/ — Medical and recreational cannabis is becoming big business. The size of the cannabis market in the Americas is $12 billion, with an estimated five-year CAGR of 15%. Additionally, venture funding continues to grow exponentially, rising from $10 million in 2014 to more than $250 million in 2018. To better understand this nascent industry, the team at Lux Research, a leading provider of tech-enabled research and advisory services for technology innovation, identified and analyzed the opportunities and barriers across the cannabis value chain in a new report, “Cannabusiness Innovation: Opportunities, Bottlenecks, and Barriers.”
The Lux report reveals that adapting regulatory frameworks, especially those regarding product testing and distribution, are likely to inhibit investment and impact innovation. However, the regulation framework remains dynamic, and there are innovation opportunities at every point in the value chain.
“The cannabis industry will continue to grow. North America’s favorable environment includes Canada’s recent cannabis legalization, the state-by-state U.S. regulations, and Mexico’s approval of medicinal cannabis,” said Joshua Haslun, Ph.D., analyst at Lux Research and lead author of the report. “Many other countries have begun to enact favorable cannabis regulations, but the evolving industry makes differentiating between opportunities and pitfalls difficult. The opportunities lie in innovative technologies that are readily adaptable to the cannabis industry, such as novel and sustained delivery methods, product testing, genetics and trait development, and consumer packaged goods.”
According to Lux, the cannabis value chain is divided into four segments: cannabis cultivation, distribution, processing, and consumer products. This new report breaks each segment down into categories to provide deeper insights into both opportunities and barriers. Below are some of the opportunities Lux identified:
Segment: Cannabis cultivation
Segment: Distribution
Segment: Processing
Segment: Consumer products
Lux’s “Cannabusiness Innovation: Opportunities, Bottlenecks, and Barriers” report offers details on a range of patent, funding, merger and research activity. In addition, the report delves deeper into the opportunities and challenges within each market segment and category.
For more information, download the Executive Summary.
About Lux Research
Lux Research is a leading provider of tech-enabled research and advisory services, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux empowers clients to make more informed decisions today to ensure future success.
For more information, visit www.luxresearchinc.com, visit our blog www.luxresearchinc.com/blog, connect on LinkedIn, or follow @LuxResearch.
View original content to download multimedia:http://www.prnewswire.com/news-releases/lux-research-identifies-budding-opportunities-in-the-12-billion-cannabis-industry-300866869.html
SOURCE Lux Research
FORT WORTH, Texas, Nov. 22, 2024 /PRNewswire/ -- ESHA, Inc ("ESHA") provide certain revenue cycle…
NASHVILLE, Tenn., Nov. 22, 2024 /PRNewswire/ -- Medalogix, the leading machine learning and AI company specializing…
CHICAGO, Nov. 22, 2024 /PRNewswire/ -- Kevin Brilliant left his dream job with the Chicago…
NEWARK, DE / ACCESSWIRE / November 22, 2024 / Laurel Bridge Software, a leader in…
DENVER, CO / ACCESSWIRE / November 22, 2024 / Aytu BioPharma, Inc. (the "Company" or…
Hemogenyx Pharmaceuticals plc("Hemogenyx Pharmaceuticals" or the "Company")Notice of Extraordinary General MeetingProposed Capital Reorganisation and New…